{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T10:05:54Z","timestamp":1768903554648,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:00:00Z","timestamp":1654128000000},"content-version":"am","delay-in-days":305,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.trim.2021.101417","type":"journal-article","created":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T12:03:44Z","timestamp":1622203424000},"page":"101417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The response-guided ATG treatment provides a survival benefit and KPS recovery for patients with steroid refractory acute GVHD: The Nagasaki Transplant Group Experience"],"prefix":"10.1016","volume":"67","author":[{"given":"Machiko","family":"Fujioka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidehiro","family":"Itonaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Furumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachie","family":"Kasai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hikaru","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Kitanosono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeharu","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makiko","family":"Horai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Sawayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Imaizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Hata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiyoshi","family":"Moriuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.trim.2021.101417_bb0005","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1056\/NEJM199103073241005","article-title":"Graft-versus-host disease","volume":"324","author":"Ferrara","year":"1991","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.trim.2021.101417_bb0010","first-page":"2288","article-title":"Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation","volume":"92","author":"Van Lint","year":"1998","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.trim.2021.101417_bb0015","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/sj.bmt.1700745","article-title":"A survey of the prophylaxis and treatment of acute GVHD in Europe: a report of the European Group for Blood and Marrow, Transplantation (EBMT). Chronic Leukaemia Working Party of the EBMT","volume":"19","author":"Ruutu","year":"1997","journal-title":"Bone Marrow Transplant."},{"issue":"13","key":"10.1016\/j.trim.2021.101417_bb0020","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1182\/blood-2008-07-168401","article-title":"Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes","volume":"113","author":"Mielcarek","year":"2009","journal-title":"Blood."},{"issue":"8","key":"10.1016\/j.trim.2021.101417_bb0025","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.bbmt.2012.04.005","article-title":"First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation","volume":"18","author":"Martin","year":"2012","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"3","key":"10.1016\/j.trim.2021.101417_bb0030","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1053\/bbmt.2002.v8.pm11939605","article-title":"Poor outcome in steroid-refractory graft-versus-host disease with antithymocyte globulin treatment","volume":"8","author":"Arai","year":"2002","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"3","key":"10.1016\/j.trim.2021.101417_bb0035","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.bbmt.2011.06.012","article-title":"Steroid-refractory acute GVHD: lack of long-term improved survival using new generation anticytokine treatment","volume":"18","author":"Xhaard","year":"2012","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"4","key":"10.1016\/j.trim.2021.101417_bb0040","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/sj.bmt.1705434","article-title":"Quality of life associated with acute and chronic graft-versus-host disease","volume":"38","author":"Lee","year":"2006","journal-title":"Bone Marrow Transplant."},{"issue":"10","key":"10.1016\/j.trim.2021.101417_bb0045","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/sj.bmt.1703032","article-title":"Treatment of steroid-resistant acute graft-versus-host disease with anti-thymocyte globulin","volume":"27","author":"Khoury","year":"2001","journal-title":"Bone Marrow Transplant."},{"issue":"1","key":"10.1016\/j.trim.2021.101417_bb0050","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1053\/bbmt.2002.v8.pm11858189","article-title":"Early antithymocyte globulin therapy improves survival in patients with steroid-resistant acute graft-versus-host disease","volume":"8","author":"MacMillan","year":"2002","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"2","key":"10.1016\/j.trim.2021.101417_bb0055","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/bmt.2016.247","article-title":"Low-dose thymoglobulin as second-line treatment for steroid-resistant acute GvHD: an analysis of the JSHCT","volume":"52","author":"Murata","year":"2017","journal-title":"Bone Marrow Transplant."},{"issue":"3","key":"10.1016\/j.trim.2021.101417_bb0060","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.exphem.2014.11.008","article-title":"Response-guided therapy for steroid-refractory acute GVHD starting with very-low-dose antithymocyte globulin","volume":"43","author":"Nishimoto","year":"2015","journal-title":"Exp. Hematol."},{"issue":"6","key":"10.1016\/j.trim.2021.101417_bb0065","first-page":"825","article-title":"1994 consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant."},{"issue":"12","key":"10.1016\/j.trim.2021.101417_bb0070","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"8","key":"10.1016\/j.trim.2021.101417_bb0075","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1182\/blood.V76.8.1464.1464","article-title":"A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment","volume":"76","author":"Martin","year":"1990","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.trim.2021.101417_bb0080","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.1182\/blood-2011-03-344390","article-title":"Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria","volume":"118","author":"Arai","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.trim.2021.101417_bb0085","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","article-title":"Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research","volume":"15","author":"Giralt","year":"2009","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"6","key":"10.1016\/j.trim.2021.101417_bb0090","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","article-title":"Estimation of failure probabilities in the presence of competing risks: new representations of old estimators","volume":"18","author":"Gooley","year":"1999","journal-title":"Stat. Med."},{"issue":"3","key":"10.1016\/j.trim.2021.101417_bb0095","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant."},{"issue":"4","key":"10.1016\/j.trim.2021.101417_bb0100","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/sj.bmt.1702805","article-title":"Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan","volume":"27","author":"Kanda","year":"2001","journal-title":"Bone Marrow Transplant."},{"issue":"4","key":"10.1016\/j.trim.2021.101417_bb0105","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.bbmt.2013.01.011","article-title":"Distinct clinical features of infectious complications in adult T cell leukemia\/lymphoma patients after allogeneic hematopoietic stem cell transplantation: a retrospective analysis in the Nagasaki transplant group","volume":"19","author":"Itonaga","year":"2013","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"2","key":"10.1016\/j.trim.2021.101417_bb0110","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/hon.2712","article-title":"Treatment with mogamulizumab or lenalidomide for relapsed adult T-cell leukemia\/lymphoma after allogeneic hematopoietic stem cell transplantation: the Nagasaki transplant group experience","volume":"38","author":"Sakamoto","year":"2020","journal-title":"Hematol. Oncol."},{"issue":"17","key":"10.1016\/j.trim.2021.101417_bb0115","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1182\/blood-2010-11-319509","article-title":"Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium","volume":"117","author":"Pidala","year":"2011","journal-title":"Blood."},{"issue":"10","key":"10.1016\/j.trim.2021.101417_bb0120","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.bbmt.2017.06.011","article-title":"Quality of life after allogeneic hematopoietic cell transplantation according to affected organ and severity of chronic graft-versus-host disease","volume":"23","author":"Kurosawa","year":"2017","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"9","key":"10.1016\/j.trim.2021.101417_bb0125","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.bbmt.2019.05.016","article-title":"Resolved versus active chronic graft-versus-host disease: impact on post-transplantation quality of life","volume":"25","author":"Kurosawa","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"10","key":"10.1016\/j.trim.2021.101417_bb0130","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/bmt.2014.106","article-title":"Extracorporeal photopheresis for treatment of adults and children with acute GVHD: UK consensus statement and review of published literature","volume":"49","author":"Das-Gupta","year":"2014","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.trim.2021.101417_bb0135","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3389\/fimmu.2019.00547","article-title":"Shaping of CD56 bri natural killer cells in patients with steroid-refractory\/resistant acute graft-vs.-host disease via extracorporeal photopheresis","volume":"10","author":"Ni","year":"2019","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.trim.2021.101417_bb0140","first-page":"405","article-title":"The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease","volume":"91","author":"Greinix","year":"2006","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.trim.2021.101417_bb0145","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/bmt.2010.68","article-title":"Therapy of steroid-refractory acute GVHD with CD52 antibody alemtuzumab is effective","volume":"46","author":"Schub","year":"2011","journal-title":"Bone Marrow Transplant."},{"issue":"5","key":"10.1016\/j.trim.2021.101417_bb0150","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.bbmt.2019.08.029","article-title":"A phase 3 randomized study of remestemcel-L versus placebo added to second-line therapy in patients with steroid-refractory acute graft-versus-host disease","volume":"26","author":"Kebriaei","year":"2020","journal-title":"Biol. Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.trim.2021.101417_bb0155","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89798","article-title":"An early-biomarker algorithm predicts lethal graft-versus-host disease and survival","volume":"2","author":"Hartwell","year":"2017","journal-title":"JCI Insight"},{"issue":"23","key":"10.1016\/j.trim.2021.101417_bb0160","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1182\/bloodadvances.2019000791","article-title":"The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease","volume":"3","author":"Srinagesh","year":"2019","journal-title":"Blood Adv."},{"issue":"25","key":"10.1016\/j.trim.2021.101417_bb0165","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1182\/blood-2018-01-822957","article-title":"MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD","volume":"131","author":"Major-Monfried","year":"2018","journal-title":"Blood"}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327421000575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327421000575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T18:00:53Z","timestamp":1760810453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327421000575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":33,"alternative-id":["S0966327421000575"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2021.101417","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The response-guided ATG treatment provides a survival benefit and KPS recovery for patients with steroid refractory acute GVHD: The Nagasaki Transplant Group Experience","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2021.101417","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101417"}}